Latest News and Press Releases
Want to stay updated on the latest news?
-
SNIPR BIOME today announced that the first patient has been dosed in its Phase 1b study of SNIPR001 in patients with hematological cancer.
-
Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "CRISPR Market by Offering [Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)], Application...
-
Cytosurge appoints Magid Haddouchi, PhD, as CCO and joins key events worldwide to showcase FluidFM tech for single-cell and genome engineering solutions.
-
CAMBRIDGE, Mass., March 26, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based...
-
Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Global CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2029" report has been added to ResearchAndMarkets.com's offering. Antecedently,...
-
Grant of a patent on February 26th 2025 by the European Patent Office protecting the newly-discovered and characterised CRISPR-CasS system.
-
Consumer Genomics Market Size to Hit USD 10.8 Billion by 2032, Growing at a 24.6% CAGR - SNS Insider
Pune, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Global Consumer Genomics Market Size & Growth Analysis: “According to SNS Insider, the global Consumer Genomics Market size was valued at USD 1.5 Billion...
-
New York, United States, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Genotyping involves analyzing DNA sequences to ascertain the genetic makeup of the genotypes of living things, such as people, plants,...
-
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing Market by Product & Service, by Application, by End-User, and By Region" report has been added to ...
-
ERS Genomics (‘ERS’), the CRISPR licensing company, today announces the launch of its Express License platform.